1 Min Read
March 29 (Reuters) - Navidea Biopharmaceuticals Inc :
* Navidea provides corporate update and reports full year 2016 results
* Q4 loss per share $0.02
* Q4 revenue $3.4 million versus $4.3 million Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.